Search

everythinglearnresearchcommunity

for

Search:↓

The timing of when the gene Bmal1 is active affects aging and survival, with its absence during development, not adulthood, leading to premature aging.

Targeted cancer therapies often cause serious skin problems that need careful management.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Exosomes could potentially enhance tissue repair and regeneration with lower rejection risk and easier production than live cell therapies.

Modulating BMP activity changes the number, size, shape, and type of ectodermal organs.

Asia has made significant progress in tissue engineering and regenerative medicine, but wider clinical use requires more development.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Human beard hair medulla contains a unique and complex mix of keratins not found in other human tissues.

The skin protects the body and is constantly renewed by stem cells; disruptions can lead to cancer.

Liposomes better deliver minoxidil for hair loss treatment than niosomes.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

PDRN helps repair tissue and improve wound healing with a high safety profile.

Triparanol therapy can cause hair loss and skin dryness without inflammation or damage to hair follicles or skin structures.

Niosomes are promising for skin drug delivery, offering benefits like improved drug penetration and stability.

The study identified and characterized new keratin genes linked to hair follicles and epithelial tissues.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

European guidelines recommend regular eye and ear exams, skin care, vitamin D supplements, and cautious use of medications for managing congenital ichthyoses.

Brain-Derived Neurotrophic Factor (BDNF) slows down hair growth and promotes hair follicle regression.

The document concludes that the effectiveness of platelet rich plasma in aesthetic surgery is unclear due to inconsistent reporting and lack of objective measures in studies.

Wnt10b makes hair follicles bigger, but DKK1 can reverse this effect.

Oral retinoids are effective for severe skin conditions but require careful use due to side effects.

Platelet lysate is a promising, cost-effective option for regenerative medicine with potential clinical applications.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

The study found that bioengineered hair follicles work when using cells from the same species but have issues when combining human and mouse cells.

Mice with human skin protein K8 had more skin problems and cancer.

Nanoparticles show promise for better wound healing, but more research is needed to ensure safety and effectiveness.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Understanding the genetics of rare inherited ichthyosis syndromes is key for better treatments and genetic counseling.

Nanoparticulate systems improve drug delivery by controlling release, protecting drugs, changing absorption and distribution, and concentrating drugs in targeted areas.